NCT04840771View on ClinicalTrials.gov

Predictive OCTA Biomarkers After Endoscopic Endonasal Pituitary Surgery

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

July 30, 2020

Study Completion Date

July 31, 2020

Conditions
Pituitary Adenoma
Interventions
PROCEDURE

Endoscopic Endonasal Pituitary Surgery

Surgical treatment consisted of an endoscopic endonasal approach using a rigid 0-degree endoscope, 18 cm in length and 4 mm in diameter.

Trial Locations (1)

80100

"University of Naples Federico II", Naples

All Listed Sponsors
lead

Federico II University

OTHER

NCT04840771 - Predictive OCTA Biomarkers After Endoscopic Endonasal Pituitary Surgery | Biotech Hunter | Biotech Hunter